Your browser doesn't support javascript.
loading
lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516.
Wang, Zhuo; Xu, Ruqing.
Afiliación
  • Wang Z; Department of Breast Surgery, The First People's Hospital of Jingzhou, Jingzhou 434000, Hubei, People's Republic of China.
  • Xu R; Department of Breast Surgery, The First People's Hospital of Jingzhou, Jingzhou 434000, Hubei, People's Republic of China.
Cancer Manag Res ; 12: 7753-7760, 2020.
Article en En | MEDLINE | ID: mdl-32922076
ABSTRACT

INTRODUCTION:

Breast cancer is a serious threat to human health. It is meaningful to study the pathogenesis of breast cancer. lncRNAs have been found to play vital roles in numerous biological processes including development, immunology and cancer.

METHODS:

qRT-PCR was performed to examine the expressions of PART1 and miR-4516. CCK-8 assay, colony formation assay and transwell assay were used to examine the progression of breast cancer cells.

RESULTS:

In this study, we showed that lncRNA PART1 was highly expressed in breast cancer cells. Knockdown of PART1 induced decreased proliferation, invasion and migration of breast cancer cells. Moreover, we found that PART1 can bind to miR-4516 directly. We also found that inhibition of miR-4516 could rescue the decreased proliferation, migration and invasion of breast cancer cells induced by knockdown of PART1.

DISCUSSION:

lncRNA PART1 and miR-4516 were proven to be involved in the progression of many cancers. However, the roles of lncRNA PART1 and miR-4516 in the regulation of breast cancer remain unknown. Here, we demonstrated that PART1 can bind to miR-4516 to decrease the expression of miR-4516 and promote the development of breast cancer.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article